Visiting Worker

Research Group Home Page: 
Jodrell Group

Work address: 
Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
Publications: 

Cancer: The Tumor-Driven Disease of the Host.

E-pub date: 30 Jun 2018


A type III complement factor D deficiency: Structural insights for inhibition of the alternative pathway.

E-pub date: 06 Mar 2018


A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy.

E-pub date: 28 Feb 2018


Cancer Immunotherapy Trials Underutilize Immune Response Monitoring.

E-pub date: 31 Jan 2018


New Model for Estimating Glomerular Filtration Rate in Patients With Cancer.

E-pub date: 20 Aug 2017


Cancer immunotherapy trial registrations increase exponentially but chronic immunosuppressive glucocorticoid therapy may compromise outcomes.

E-pub date: 01 Jul 2017


Connecting the Metabolic and Immune Responses to Cancer.

E-pub date: 31 May 2017


A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab.

E-pub date: 01 Apr 2017


Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity.

E-pub date: 08 Nov 2016


Chemotherapy vs supportive care alone for relapsed gastric, gastroesophageal junction, and oesophageal adenocarcinoma: a meta-analysis of patient-level data.

E-pub date: 16 Feb 2016


Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy.

E-pub date: 01 Oct 2015


The use of error-category mapping in pharmacokinetic model analysis of dynamic contrast-enhanced MRI data.

E-pub date: 01 Feb 2015


Cross-sectional analysis of data from the U.S. clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke.

E-pub date: 31 Aug 2014


Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008.

E-pub date: 31 Aug 2014


Panhypopituitarism secondary to a solitary hypothalamic metastasis.

E-pub date: 23 May 2014


Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.

E-pub date: 31 Jan 2014


Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.

E-pub date: 10 Dec 2013


Adjuvant therapy in renal cell carcinoma-past, present, and future.

E-pub date: 31 Aug 2013


Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.

E-pub date: 30 Oct 2012


Biopharmaceuticals and monoclonal antibodies in oncology trials–a cross-sectional analysis.

E-pub date: 31 Jan 2011


Exploring new routes for neuroprotective drug development in traumatic brain injury.

E-pub date: 14 Apr 2010


Show all